Our findings demonstrate that PF4 exert an antidepressant effect, at least in part, by suppressing neuroinflammatory responses within the NAc. This work identifies PF4 as a novel and promising therapeutic target for the treatment of major depression.
Li et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: